Cargando…

Adding Value of MRI over CT in Predicting Peritoneal Cancer Index and Completeness of Cytoreduction

Background: This study aimed to investigate the adding value of MRI over CT for preoperative cytoreductive surgery with hyperthermic intraperitoneal chemotherapies (CRS/HIPEC). Methods: Imaging and intraoperative peritoneal cancer index (PCI) were calculated in 62 patients with peritoneal metastasis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Chia-Ni, Huang, Weh-Shih, Huang, Tzu-Hao, Chen, Chao-Yu, Huang, Cheng-Yi, Wang, Ting-Yao, Liao, Yu-San, Lee, Li-Wen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8068380/ https://www.ncbi.nlm.nih.gov/pubmed/33917997 http://dx.doi.org/10.3390/diagnostics11040674

Ejemplares similares

Cytoreductive Surgery of Colorectal Peritoneal Metastases: Outcomes after Complete Cytoreductive Surgery and Systemic Chemotherapy Only
por: Désolneux, Grégoire, et al.
Publicado: (2015)

Cytoreduction surgery and hyperthermic intraperitoneal chemotherapy for treating advanced peritoneal metastases of hepatocellular carcinoma
por: Hung, Kuo-Chen, et al.
Publicado: (2020)

Limitations of laparoscopy to assess the peritoneal cancer index and eligibility for cytoreductive surgery with HIPEC in peritoneal metastasis
por: Yurttas, Can, et al.
Publicado: (2022)

Implications of peritoneal cancer index distribution on patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
por: Wong, Jolene Si Min, et al.
Publicado: (2022)

Cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis in the elderly
por: Huang, Yeqian, et al.
Publicado: (2015)

Quality of life and symptom distress after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
por: Wang, Ya-Fen, et al.
Publicado: (2022)

The Peritoneal Cancer Index is a Strong Predictor of Incomplete Cytoreductive Surgery in Ovarian Cancer
por: Jónsdóttir, Björg, et al.
Publicado: (2020)

Multicystic peritoneal mesothelioma treated with complete cytoreductive surgery, peritonectomy and hyperthermic intra-peritoneal chemotherapy—A case report
por: Padmanabhan, Naveen, et al.
Publicado: (2020)

Cytoreductive Surgery and HIPEC for Peritoneal Carcinomatosis in the Elderly
por: Spiliotis, J. D., et al.
Publicado: (2014)

Postoperative Peritonitis Without An Underlying Digestive Fistula After Complete Cytoreductive Surgery Plus HIPEC
por: Honoré, Charles, et al.
Publicado: (2013)

Effect of HIPEC on Peritoneal Recurrence in Peritoneal Metastasis Treated With Cytoreductive Surgery: A Systematic Review
por: Yap, Daniel Ren Yi, et al.
Publicado: (2021)

The Impact of Multidisciplinary Team Approach on Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis
por: Hung, Hao-Chien, et al.
Publicado: (2021)

Cytoreduction and HIPEC in the treatment of “unconventional” secondary peritoneal carcinomatosis
por: Cardi, Maurizio, et al.
Publicado: (2015)

Is Cytoreductive Surgery Possible in Cervical Cancer Peritoneal Carcinomatosis?
por: Duzgun, Ozgul, et al.
Publicado: (2021)

Two-step cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei with high peritoneal carcinomatosis index
por: Trilling, Bertrand, et al.
Publicado: (2021)

Early sepsis identification following cytoreductive surgery for peritoneal malignancy
por: Wilson, Darius Cameron, et al.
Publicado: (2020)

Current role for cytoreduction and HIPEC for gastric cancer with peritoneal disease
por: Khan, Hamza, et al.
Publicado: (2022)

CT, MRI and PET imaging in peritoneal malignancy
por: Patel, Chirag M., et al.
Publicado: (2011)

The importance of synchronicity in the management of colorectal peritoneal metastases with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
por: Wong, Jolene Si Min, et al.
Publicado: (2020)

Acinetobacter Peritoneal Dialysis Peritonitis: A Changing Landscape over Time
por: Chao, Chia-Ter, et al.
Publicado: (2014)

Reply to “Letter to the Editor on Yurttas C et al. Limitations of laparoscopy to assess the peritoneal cancer index and eligibility for cytoreductive surgery with HIPEC in peritoneal metastasis”
por: Yurttas, Can, et al.
Publicado: (2023)

Microscopic Peritoneal Residual Disease after Complete Macroscopic Cytoreductive Surgery for Advanced High Grade Serous Ovarian Cancer
por: Azaïs, Henri, et al.
Publicado: (2020)

Prediction of suboptimal cytoreductive surgery in patients with advanced ovarian cancer based on preoperative and intraoperative determination of the peritoneal carcinomatosis index
por: Llueca, Antoni, et al.
Publicado: (2018)

Risk factors for gastric perforation after cytoreductive surgery in patients with peritoneal carcinomatosis: Splenectomy and increased body mass index
por: Angeles, Martina Aida, et al.
Publicado: (2021)

Cytoreductive Surgery for Peritoneal Carcinomatosis from Gastric Cancer: Technical Details
por: Boerner, Thomas, et al.
Publicado: (2021)

Secondary surgical cytoreduction needs to be assessed taking into account surgical technique, completeness of cytoreduction, and extent of disease
por: Segura-Sampedro, Juan José, et al.
Publicado: (2020)

Neoadjuvant systemic and hyperthermic intraperitoneal chemotherapy combined with cytoreductive surgery for gastric cancer patients with limited peritoneal metastasis: a prospective cohort study
por: Yu, Pengfei, et al.
Publicado: (2020)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from ovarian cancer
por: Piso, Pompiliu, et al.
Publicado: (2004)

Management of Inguinal Involvement of Peritoneal Surface Malignancies by Cytoreduction and HIPEC with Inguinal Perfusion
por: Shachar, Yair, et al.
Publicado: (2015)

Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer with peritoneal metastasis
por: Lin, En-Kwang, et al.
Publicado: (2016)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in treatment of gastric cancer with peritoneal carcinomatosis
por: Ellison, Lynne M., et al.
Publicado: (2017)

Outcomes of multicystic peritoneal mesothelioma treatment with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
por: Zahid, A, et al.
Publicado: (2020)

Impact of sociodemographic factors on outcomes in patients with peritoneal malignancies following cytoreduction and chemoperfusion
por: Cantos, Adriana, et al.
Publicado: (2022)

Artificial intelligence weights the importance of factors predicting complete cytoreduction at secondary cytoreductive surgery for recurrent ovarian cancer
por: Bogani, Giorgio, et al.
Publicado: (2018)

Risk, Severity, and Predictors of Obstructive Sleep Apnea in Hemodialysis and Peritoneal Dialysis Patients
por: Huang, Shih-Ting, et al.
Publicado: (2018)

Clinical outcomes of complete cytoreduction with concurrent liver resection followed by hyperthermic intraperitoneal chemotherapy for synchronous peritoneal and liver metastatic colorectal cancer
por: Jeon, Youngbae, et al.
Publicado: (2019)

Experience of applying cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for ovarian teratoma with malignant transformation and peritoneal dissemination
por: Yu, Hsin-Hsien, et al.
Publicado: (2019)

Pre-therapy CT scan showing peritoneal thickening from metastatic renal pelvis carcinoma patients
por: Liao, Tzu-Yao, et al.
Publicado: (2018)

The PEritoneal SUrface CAlculator (PESUCA): A new tool to quantify the resected peritoneal surface area after cytoreductive surgery
por: Schredl, Philipp, et al.
Publicado: (2020)

Hepatectomy for metachronous colorectal liver metastases following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastases: a report of three cases
por: Ito, Kyoji, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0cr1vtbekunto5c7aqfrkg5mfq